TrialChinese medical journal2026

Efficacy and safety of guselkumab in Chinese patients with moderate-to-severe plaque psoriasis: A randomized, double-blind, placebo-controlled trial.

Kun Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.